AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
325 hedge funds and large institutions have $4.85B invested in Amedisys in 2019 Q4 according to their latest regulatory filings, with 80 funds opening new positions, 96 increasing their positions, 107 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 107
50% less call options, than puts
Call options by funds: $24.4M | Put options by funds: $48.7M
Holders
325
Holding in Top 10
3
Calls
$24.4M
Puts
$48.7M
Top Buyers
| 1 | +$54.9M | |
| 2 | +$29.8M | |
| 3 | +$20.8M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$14.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.9M |
Top Sellers
| 1 | -$84.6M | |
| 2 | -$49.2M | |
| 3 | -$25.1M | |
| 4 |
Bank of New York Mellon
New York
|
-$23.5M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$22.8M |